Burkholderia pseudomallei: Challenges for the Clinical Microbiology Laboratory—a Response from the Front Line
Author(s) -
David A. B. Dance,
Direk Limmathurotsakul,
Bart J. Currie
Publication year - 2017
Publication title -
journal of clinical microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.349
H-Index - 255
eISSN - 1070-633X
pISSN - 0095-1137
DOI - 10.1128/jcm.02378-16
Subject(s) - melioidosis , burkholderia pseudomallei , clinical microbiology , microbiology and biotechnology , burkholderia , incidence (geometry) , biology , virology , bacteria , genetics , physics , optics
The minireview by Hemajarata et al. (1) is timely since the global incidence of melioidosis has probably been grossly underestimated (2). However, the review reflects a very U.S. “select agent”-orientated perspective. In some parts of the world, laboratories isolate Burkholderia pseudomallei on an almost daily basis; our own laboratories diagnose more than 600 cases of culture-positive melioidosis each year, giving us a different perspective
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom